Drugs / HemPhar
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT04634136 Comparator | Oct 2020 → Dec 2023 | spastic cerebral palsy | University Medical Centre Ljubljana | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HemPhar | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04634136 ↗ |
| Known as | Full-spectrum Medical Canabis Product (HemPhar) | “Full-spectrum Medical Canabis Product (HemPhar)” NCT04634136 ↗ |
| Route | Oral | “as an oral oily solution for oral application” NCT04634136 ↗ |